Inhibitors of AP-1 and NF-&kgr;B Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|9|2|219-227

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.2, 2002-01, pp. : 219-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heme Arginate Pretreatment Attenuates Pulmonary NF-&kgr;B and AP-1 Activation Induced by Hemorrhagic Shock via Heme Oxygenase-1 Induction

By  

Medicinal Chemistry, Vol. 2, Iss. 3, 2006-05 ,pp. : 272-274

Bentham Science Publishers

Access to resources Recommend Favorite

Naturally Occurring NF-&kgr;B Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 945-951

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B in Type 1 Diabetes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 208-217

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of NF-&kgr;B and Proteasome Activity in Tumors: Can We Improve the Therapeutic Potential of Topoisomerase I and Topoisomerase II Poisons

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1945-1958

Bentham Science Publishers

Access to resources Recommend Favorite